Feedback / Questions
glenzocimab (ACT 017) - Acticor Biotech
https://journals.sagepub.com/doi/reader/10.1177/17474930231192010
C. Molina1; E.Toledano2; A. Comenducci2; Y. Plétan2; A. Meilhoc2; S. Binay2; G. Avenard2; M. Mazighi3
Sep 9, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next